News & Insights

XBOW, the leader in autonomous offensive security, announces its $120 million Series C financing, valuing the company at over $1 billion, with DFJ Growth and Northzone leading the round, and participation from new investors Sofina and Alkeon Capital, as well as existing investors Altimeter, NFDG Ventures, and Sequoia Capital

Leading platform for coordinated vulnerability disclosure, XBOW, announces its $75 million Series B financing led by Apoorv Agrawal of Altimeter

Clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, Newleos Therapeutics, announces its $93.5 million Series A financing 

Gunderson Dettmer has elected nine new partners effective January 1, 2026, continuing to serve clients throughout the innovation economy

LMG Life Sciences recognizes Gunderson Dettmer with Impact Deal of the Year and names Boston associate Joel Diamond the US Rising Star—Financial and Corporate in its 2025 Life Sciences Americas Awards

LMG Sciences shortlists Gunderson Dettmer and Boston associate Joel Diamond for the 2025 LMG Life Sciences Americas Awards